Last Updated: 11 June 2019
has approximately 100 employees (29 partners) and covers the full spectrum of business law. The firm's life sciences team consists of nine partners and a number of attorneys that advise clients on contentious and non-contentious matters. The team provides legal services to both Norwegian and foreign ... pharmaceutical companies, biotech companies, medical device companies and food enterprises, as well as patient organisations and government institutions. Grette offers a range of services for the life sciences industries. The firm's specialist expertise includes: start-ups; financing; M&A; regulatory; competition and market access; patent litigation; intellectual property; public procurement; marketing law; medicinal products. Grette has in-depth knowledge of regulatory law and practice and of the co-operation between the competent authorities within the EEA, as well as the European Commission and the European Medicines Agency. The firm's knowledge also covers national and EU-regulatory requirements on pricing and reimbursement of medicinal products, on advertising and on the regulatory requirements applicable to wholesalers and pharmacies. Grette's experience from working both with the public sector as well as assisting pharmaceutical companies is extremely valuable when providing expert assistance in the pharmaceutical field.